Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-11-000010
Filing Date
2011-01-27
Accepted
2011-01-27 16:08:21
Documents
1
Period of Report
2011-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 42268
  Complete submission text file 0000908662-11-000010.txt   44982
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Issuer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-13789 | Film No.: 11552355
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Reporting) CIK: 0001297709 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-13789 | Film No.: 11552356